These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Non-occupational postexposure HIV prophylaxis: clinical issues and public health questions. Mayer KH; Kwong J; Singal R; Boswell S Med Health R I; 2000 Jul; 83(7):210-3. PubMed ID: 10934823 [No Abstract] [Full Text] [Related]
4. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus. Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Pinkerton SD; Holtgrave DR; Pinkerton HJ Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509 [TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of pre-exposure prophylaxis in men who have sex with men in the United States: an epidemic model. Koppenhaver RT; Sorensen SW; Farnham PG; Sansom SL J Acquir Immune Defic Syndr; 2011 Oct; 58(2):e51-2. PubMed ID: 21921730 [No Abstract] [Full Text] [Related]
7. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV. Frothingham R Arch Intern Med; 1998 Jul; 158(13):1470-2. PubMed ID: 9665362 [No Abstract] [Full Text] [Related]
8. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. Pinkerton SD; Holtgrave DR; Bloom FR AIDS; 1998 Jun; 12(9):1067-78. PubMed ID: 9662204 [TBL] [Abstract][Full Text] [Related]
10. Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance. Horberg M; Raymond B Am J Prev Med; 2013 Jan; 44(1 Suppl 2):S125-8. PubMed ID: 23253752 [No Abstract] [Full Text] [Related]
17. HIV postexposure prophylaxis after sexual assault. Stevens L; Brown MA Nurse Pract Forum; 2001 Dec; 12(4):192-8. PubMed ID: 11889687 [TBL] [Abstract][Full Text] [Related]
18. Postexposure prophylaxis after sexual exposure to HIV. Roland ME Curr Opin Infect Dis; 2007 Feb; 20(1):39-46. PubMed ID: 17197880 [TBL] [Abstract][Full Text] [Related]
19. Providing antiretroviral therapy for HIV infection. Steinbrook R N Engl J Med; 2001 Mar; 344(11):844-6. PubMed ID: 11248164 [No Abstract] [Full Text] [Related]
20. Should preventive antiretroviral treatment be offered following sexual exposure to HIV? The case for. Desmond NM; Coker RJ Sex Transm Infect; 1998 Apr; 74(2):144-5. PubMed ID: 9634330 [No Abstract] [Full Text] [Related] [Next] [New Search]